ArticleCureus2025
A Double Threat: Concurrent Non-ST-Elevation Myocardial Infarction and Transient Ischemic Attack Symptoms Revealing Triple-Vessel Coronary Artery Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Impaired ventricular wall motion and reduced ejection fraction after an acute myocardial infarction promote blood stasis - especially in hypokinetic or akinetic segments - activating coagulation pathways, platelet aggregation, and thrombus formation. Concurrent endothelial injury from ischemia further exposes thrombogenic surfaces, and if the thrombus embolizes, it can trigger serious neurologic events such as stroke or transient ischemic attack (TIA). We describe the case of a 56-year-old man with hypertension and methamphetamine use who presented with chest pain, dyspnea, and transient left-sided weakness. Work-up revealed elevated troponin, severely calcified triple-vessel coronary disease, and an apical mural thrombus with an ejection fraction of 45%, confirmed on transthoracic echocardiography, with subsequent paroxysmal atrial flutter. Methamphetamine use, known to accelerate atherosclerosis and heighten thromboembolic risk, likely compounded his coronary disease. The patient was anticoagulated with enoxaparin, bridging to warfarin, and discharged for follow-up imaging and surgical evaluation. This case highlights the need for heightened vigilance, prompt anticoagulation, and thorough cardiac evaluation for mural thrombus and embolic complications in methamphetamine-associated myocardial injury, even when initial cerebrovascular imaging is negative.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.